/Investor DB

InnerProduct Partners — 2019 Investments

1 investments dated 2019 · listed companies and verified rows first · show all

TendoNovatendonova.comin𝕏Apr 2019SEC filingmedium confidence

TendoNova develops microinvasive medical technology, including its Ocelot Nano device, to treat chronic tendon pain in patients.

BiotechHardwareHealthtechMedical DevicesAtlanta, US

Ian Campbell(Executive Officer, Director)inMark Samuels(Executive Officer)Louis Malice(Director)Luka Grujic(Director)Shawna Khouri(Director)Brett Rogers(Director)

Board seatPeter Haaland· per SEC Form D · $1.5M raise · filed Feb 2021

Co-investorsArieal Southeast Angel PartnersWalnut Venture AssociatesVentureSouth

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.